India, Sept. 18 -- NM Medical has announced the launch of Mumbai's first Open Standing MRI machine. The new facility is now operational at NM Medical's center at Marine Lines, Mumbai. Conventional cl... Read More
India, Sept. 18 -- Intuitive, a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has announced the introduction of da Vinci 5, its latest-generation rob... Read More
India, Sept. 18 -- Bengaluru-based Biomoneta Research has announced the launch of Avata Air, an indoor air-purification and microbial decontamination device, in collaboration with Panasonic. The prod... Read More
Singapore, Sept. 18 -- Singapore's regulatory body Health Sciences Authority (HSA) is expanding reliance and cooperation across Africa, Malaysia and Saudi Arabia to reduce duplicated reviews, support ... Read More
Singapore, Sept. 18 -- Australia's Monash University has collaboratd with Weill Cornell Medicine, Cornell University's academic medical institution, to tackle new research projects including mental he... Read More
Singapore, Sept. 18 -- US health tech company Massive Bio has appointed international business development consultancy Intralink to support its expansion into South Korea and build partnerships across... Read More
Singapore, Sept. 18 -- Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy's Laboratories, have entered into a distribution agreemen... Read More
Singapore, Sept. 18 -- Germany headquartered Leica Biosystems, a Danaher company and a global leader in end-to-end anatomic and digital pathology solutions, reinforces its commitment to connected path... Read More
Singapore, Sept. 18 -- Eisai and Biogen have received approval in Japan for LEQEMBI Pen, a subcutaneous autoinjector formulation of lecanemab for the treatment of early Alzheimer's disease. The appro... Read More
Singapore, Sept. 18 -- Lundbeck has received marketing authorisation from Japan's Ministry of Health, Labour and Welfare for Vyepti, or eptinezumab, for the prevention of migraine attacks in adults. ... Read More